First Treatment Protocol for PAPP-A2 Deficiency Emerging In 2015, researchers at Cincinnati Children’s discovered two genetic mutations responsible for a novel growth disorder called PAPP-A2 deficiency. Just a few months later, they turned their attention to developing a treatment protocol for a clinical trial. Now, results from the first year of the experimental therapy are in.
Read Featured ResearchResearch and Training Details | |
---|---|
Faculty | 18 |
Joint Appointment Faculty | 3 |
Research Fellows and Post Docs | 3 |
Total Annual Grant Award Dollars | $2,156,079 |
Total Annual Industry Award Dollars | $207,487 |
Clinical Activities and Training | |
---|---|
Clinical Fellows | 10 |
Inpatient Encounters | 3,955 |
Outpatient Encounters | 15,744 |